Related references
Note: Only part of the references are listed.Observed bromodomain flexibility reveals histone peptide- and small molecule ligand-compatible forms of ATAD2
Guillaume Poncet-Montange et al.
BIOCHEMICAL JOURNAL (2015)
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNFMutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies
Bhavatarini Vangamudi et al.
CANCER RESEARCH (2015)
Cell-Based Protein Stabilization Assays for the Detection of Interactions between Small-Molecule Inhibitors and BRD4
Jessica Schulze et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Readers of histone methylarginine marks
Sitaram Gayatri et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2014)
Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays
Sheraz Gul et al.
EXPERT OPINION ON DRUG DISCOVERY (2014)
BET bromodomain inhibitors: a patent review
Jean-Marc Garnier et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2014)
Residual Complexes Containing SMARCA2 (BRM) Underlie the Oncogenic Drive of SMARCA4 (BRG1) Mutation
Boris G. Wilson et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Genome-wide localization of small molecules
Lars Anders et al.
NATURE BIOTECHNOLOGY (2014)
Unravelling the genomic targets of small molecules using high-throughput sequencing
Raphael Rodriguez et al.
NATURE REVIEWS GENETICS (2014)
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers
Gregory R. Hoffman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching
Martin Philpott et al.
EPIGENETICS & CHROMATIN (2014)
Development of Multiple Cell-Based Assays for the Detection of Histone H3 Lys27 Trimethylation (H3K27me3)
Jie Qian et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2013)
Malignant genome reprogramming by ATAD2
Faycal Boussouar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2013)
A Synthetic Lethality-Based Strategy to Treat Cancers Harboring a Genetic Deficiency in the Chromatin Remodeling Factor BRG1
Takahiro Oike et al.
CANCER RESEARCH (2013)
H3K4me3 Interactions with TAF3 Regulate Preinitiation Complex Assembly and Selective Gene Activation
Shannon M. Lauberth et al.
CELL (2013)
RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist
Kevin G. McLure et al.
PLOS ONE (2013)
RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
Sarah Picaud et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151
Olivier Mirguet et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A)
Jonathan Seal et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Panagis Filippakopoulos et al.
CELL (2012)
Epigenetic protein families: a new frontier for drug discovery
Cheryl H. Arrowsmith et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Histone Deacetylase Inhibitors Globally Enhance H3/H4 Tail Acetylation Without Affecting H3 Lysine 56 Acetylation
Paul Drogaris et al.
SCIENTIFIC REPORTS (2012)
Real-Time Imaging of Histone H4K12-Specific Acetylation Determines the Modes of Action of Histone Deacetylase and Bromodomain Inhibitors
Tamaki Ito et al.
CHEMISTRY & BIOLOGY (2011)
Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery
Martin Philpott et al.
MOLECULAR BIOSYSTEMS (2011)
Histone Deacetylase Inhibitors Stimulate Histone H3 Lysine 4 Methylation in Part Via Transcriptional Repression of Histone H3 Lysine 4 Demethylases
Po-Hsien Huang et al.
MOLECULAR PHARMACOLOGY (2011)
TRIM24 links a non-canonical histone signature to breast cancer
Wen-Wei Tsai et al.
NATURE (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Covalent histone modifications - miswritten, misinterpreted and mis-erased in human cancers
Ping Chi et al.
NATURE REVIEWS CANCER (2010)
Fluorescence-based methods in the study of protein-protein interactions in living cells
Francisco Ciruela
CURRENT OPINION IN BIOTECHNOLOGY (2008)
ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERα, is required for coregulator occupancy and chromatin modification
June X. Zou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
High-resolution profiling of histone methylations in the human genome
Artern Barski et al.
CELL (2007)
Cross-talk between histone modifications in response to histone deacetylase inhibitors - MLL4 links histone H3 acetylation and histone H3K4 methylation
Karl P. Nightingale et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Direct observation of individual endogenous protein complexes in situ by proximity ligation
Ola Soderberg et al.
NATURE METHODS (2006)
A small molecule-kinase interaction map for clinical kinase inhibitors
MA Fabian et al.
NATURE BIOTECHNOLOGY (2005)
Chromatin binding of the fission yeast replication factor mcm4 occurs during anaphase and requires ORC and cdc18
SE Kearsey et al.
EMBO JOURNAL (2000)
Share Paper
